西门子全自动发光免疫分析仪检测慢性肾脏疾病患者肿瘤标志物α-甲胎蛋白、糖类抗原125的价值探讨
摘要
关键词
全文:
PDF参考
[1]陈洛海,张雨,陈旻湖,等.肿瘤标志物癌胚抗原、甲胎蛋白、糖类抗原125和糖类抗原19-9在胃肠胰神经内分泌肿瘤中的升高情况及其对预后评估的价值[J].中华胃肠外科杂志,2017,20(09):1002-1008. [2] Nakagawa S, Yamashita Y I, Umezaki N, et al. Serum Marker Score Based on Prognostic Nutrition Index, Carcinoembryonic Antigen, and Carbohydrate Antigen 19-9 Is Associated With Recurrence for Patients Undergoing Surgery for Pancreatic Ductal Adenocarcinoma[J].Pancreas,2018,47(9):1130-1134. [3]李一珂,冯婷,邓穗敏,等.磁免疫和荧光免疫传感器的构建及其在检测甲胎蛋白中的应用[J].光谱学与光谱分析,2017,37(6):1667-1672. [4]梁晖,张玉琪,赵亚鹏,等.28例颅内生殖细胞肿瘤血清肿瘤标志物与免疫组化对照观察[J].中华神经外科杂志,2017,33(6):605-609. [5]郭明明,肖华龙,周剑波,等.时间分辨荧光免疫层析法联合检测血清肿瘤标志物[J].中华核医学与分子影像杂志,2018,38(4):266-270. [6]程田,唐振林.甲胎蛋白低中浓度肝细胞癌AFP-L3和Hsp90α联合检测临床意义[J].中华肿瘤防治杂志,2018,25(21):42-45. [7]张玉扬,赵林,董奇观.原发性肝癌切除术后行肝动脉化疗栓塞效果及对患者血清AFP、CA19-9水平的影响[J].山东医药,2018,33(2):52-54. [8]Yan Z, Wang Y, Li S, et al. Hypertension Control in Adults with CKD in China: Baseline Results from the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE)[J].American Journal of Hypertension,2018,31(4):486-494. [9]沈海滢,王晓倩,王云云,等.基于石英毛细管载体的血清甲胎蛋白灰度分析免疫检测法[J].分析化学,2017,45(1):83-88. [10]王京艳,王华明,刘妍,等.血清白细胞介素-6和γ-谷氨酰转移酶联合检测对TACE治疗AFP阴性肝癌患者的疗效与预后评价[J].解放军医学杂志,2019,66(5):394-399. [11]Rheude T, Pellegrini C, Reinhard W, et al. Determinants of Elevated Carbohydrate Antigen 125 in Patients with Severe Symptomatic Aortic Valve Stenosis Referred for Transcatheter Aortic Valve Implantation.[J].Biomarkers,2018,23(3):299-304. [12]袁川淑,杨凯,唐洪,等.血清肿瘤标志物Cyfra21-1、SCCAg、Ferritin、CEA、CA19-9和AFP对口腔/口咽鳞癌的诊断价值[J].重庆医科大学学报,2017,53(9):1066-1071. [13]Woo V, Connelly K, Lin P, et al. The role of sodium glucose cotransporter-2 (SGLT-2) inhibitors in heart failure and chronic kidney disease in type 2 diabetes[J].Current Medical Research and Opinion,2019,35(1):1-13. [14]汤军,欧俐苹,陈玲,等.4种血清肿瘤标志物及粪便隐血的联合检测在DukesB期结肠癌诊断中的应用[J].重庆医学,2017,46(22):55-58. [15]Toprak O, Kurt H, Sarı Y,et al.Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study.[J].Kidney & Blood Pressure Research,2017,42(1):33-42.
(82 摘要 Views, 54 PDF Downloads)
Refbacks
- 当前没有refback。